CEO/President, 10% Owner of Bruker BioSciences Corp. (BRKR, Financial) Frank H Laukien buys 75,000 shares of BRKR on 07/31/2009 at an average price of $10.11 a share.
As of February 26 2008 the renamed BRUKER CORPORATION has become the parent company of the entire Bruker group of companies. After the closing of the acquisition of the Bruker BioSpin Group Bruker Corporation now operates in two segments the life science and analytical (LSA) systems segment and the international advanced superconductor (IAS) segment. Bruker BioSciences Corp. has a market cap of $1.65 billion; its shares were traded at around $10.06 with a P/E ratio of 23.95 and P/S ratio of 1.49.
Recent Trades of Bruker BioSciences Corp. by CEO:
Recent Trades of Bruker BioSciences Corp. by Directors and Officers:
As of February 26 2008 the renamed BRUKER CORPORATION has become the parent company of the entire Bruker group of companies. After the closing of the acquisition of the Bruker BioSpin Group Bruker Corporation now operates in two segments the life science and analytical (LSA) systems segment and the international advanced superconductor (IAS) segment. Bruker BioSciences Corp. has a market cap of $1.65 billion; its shares were traded at around $10.06 with a P/E ratio of 23.95 and P/S ratio of 1.49.
Recent Trades of Bruker BioSciences Corp. by CEO:
- Buy: CEO/President, 10% Owner Frank H Laukien bought 100,000 shares of BRKR stock on 05/07/2009 at the average price of $7.28; the price of the stock has increased by 38.19% since.
- Buy: CEO/President, 10% Owner Frank H Laukien bought 125,000 more shares of BRKR stock on 03/09/2009 at the average price of $4.2; the price of the stock has increased by 139.52% since.
Recent Trades of Bruker BioSciences Corp. by Directors and Officers:
- Sell: 10% Owner Marc M Laukien sold 2,100,000 shares of BRKR stock on 05/07/2009 at the average price of $6.91; the price of the stock has increased by 45.59% since.
